Products

What will AGI do for Acetaminophen/cinnamedrine/pamabrom?

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is an adrenergic agonist with the molecular formula C19H23NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier Y1245J8012, chemically known as benzenemethanol, alpha-(1-(methyl(3-phenyl-2-propenyl)amino)ethyl)- but more generally known as cinnamedrine, which bears U.S. National Institutes of Health Compound Identifier 5370611. The European Medicines Agency schedules Cinnamedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06301MIG. The term CINNAMEDRINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). The third component of this combination drug is a diuretic with the molecular formula C7H7BrN4O2.C4H11NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier UA8U0KJM72, chemically known as 8-bromo-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compound with 2-amino-2-methyl-1-propanol (1:1) but more generally known as pamabrom, which bears U.S. National Institutes of Health Compound Identifier 11806. The European Medicines Agency schedules Pamabrom in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14745MIG.